Effects of Robotic-assisted Gait Training In Non-Ambulatory Patients After Guillain-Barré Syndrome
GBS
About this trial
This is an interventional treatment trial for GBS
Eligibility Criteria
Inclusion Criteria:
- Clinical diagnosis of GBS;
- Age between 18 and 65 years;
- Period of GBS is between 4 and 8 weeks;
- severe walking disabilities, defined as a GBS disability score of 2-4;
Exclusion Criteria:
- An unstable phase of disease;
- Disorders preventing RAGT(eg, unstable cardiovascular, respiratory disease ,orthopedic, or neurological condition, unhealed decubitus, orthostatic hypotension etc.) ;
- Severe cognitive impairment preventing meaningful communication;
- Body weight more than 100 kg;
- Pregnancy;
Sites / Locations
- Tianjin Medical University General Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
RAGT treatment group
controls
Robotic-assisted gait training (RAGT)is an effective alternative to treadmill therapy with partial body weight in intense gait rehabilitation after some neuropathy. The investigators use LokoHelp for training, which is provided to the feet and the patient actively controls the knee and hip joints. The participants of RAGT treatment group receive 30 min conventional rehabilitation and 30 min robotic-assisted gait training daily for 8 weeks.
The participants of controls receive 60 min conventional rehabilitation daily for 8 weeks. Interventions included physiotherapy for muscle strengthening, endurance and gait training; occupational therapy to improve activity of daily living (domestic, community tasks).